Renaissance Technologies (RenTech)'s ELV Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 15,573 shares of Elevance Health, Inc. (ELV) worth $4.56 M, representing 0.01% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in ELV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2016, adding 789,773 shares. Largest reduction occurred in Q4 2019, reducing 514,073 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +15,573 | New Buy | 15,573 | $292.75 |
| Q3 2025 | -53,573 | Sold Out | 0 | $0.00 |
| Q2 2025 | +53,573 | New Buy | 53,573 | $388.96 |
| Q1 2025 | -122,973 | Sold Out | 0 | $0.00 |
| Q4 2024 | +122,973 | New Buy | 122,973 | $368.90 |
| Q2 2024 | -7,973 | Sold Out | 0 | $0.00 |
| Q1 2024 | -363,500 | Reduce 97.85% | 7,973 | $518.50 |
| Q4 2023 | -137,300 | Reduce 26.99% | 371,473 | $471.56 |
| Q3 2023 | +166,100 | Add 48.47% | 508,773 | $435.42 |
| Q2 2023 | +170,500 | Add 99.03% | 342,673 | $0.44 |
| Q1 2023 | -129,900 | Reduce 43.00% | 172,173 | $0.46 |
| Q4 2022 | +3,200 | Add 1.07% | 302,073 | $0.51 |
| Q3 2022 | +239,200 | Add 400.85% | 298,873 | $454.24 |
| Q2 2022 | +59,673 | New Buy | 59,673 | $482.58 |
| Q1 2022 | -190,373 | Sold Out | 0 | $0.00 |
| Q4 2021 | +179,300 | Add 1619.25% | 190,373 | $463.54 |
| Q3 2021 | +11,073 | New Buy | 11,073 | $372.80 |
| Q1 2021 | -237,273 | Sold Out | 0 | $0.00 |
| Q4 2020 | +91,500 | Add 62.77% | 237,273 | $321.09 |
| Q3 2020 | +145,773 | New Buy | 145,773 | $268.59 |
| Q4 2019 | -514,073 | Sold Out | 0 | $0.00 |
| Q3 2019 | +514,073 | New Buy | 514,073 | $240.10 |
| Q2 2019 | -275,973 | Sold Out | 0 | $0.00 |
| Q1 2019 | +248,173 | Add 892.71% | 275,973 | $286.98 |
| Q4 2018 | +27,800 | New Buy | 27,800 | $262.63 |
| Q3 2018 | -120,673 | Sold Out | 0 | $0.00 |
| Q2 2018 | -512,600 | Reduce 80.94% | 120,673 | $238.03 |
| Q1 2018 | -38,327 | Reduce 5.71% | 633,273 | $219.70 |
| Q4 2017 | -498,373 | Reduce 42.60% | 671,600 | $225.01 |
| Q3 2017 | +302,773 | Add 34.91% | 1.17 M | $189.88 |
| Q2 2017 | -368,400 | Reduce 29.82% | 867,200 | $188.13 |
| Q1 2017 | -451,173 | Reduce 26.75% | 1.24 M | $165.38 |
| Q4 2016 | +509,973 | Add 43.34% | 1.69 M | $143.77 |
| Q3 2016 | -20,173 | Reduce 1.69% | 1.18 M | $125.31 |
| Q2 2016 | +789,773 | Add 193.95% | 1.2 M | $131.34 |
| Q1 2016 | +119,300 | Add 41.44% | 407,200 | $138.99 |
| Q4 2015 | -463,873 | Reduce 61.70% | 287,900 | $139.44 |
| Q3 2015 | +724,473 | Add 2653.75% | 751,773 | $140.00 |
| Q2 2015 | +27,300 | New Buy | 27,300 | $164.14 |
| Q1 2015 | -90,773 | Sold Out | 0 | $0.00 |
| Q4 2014 | +90,773 | New Buy | 90,773 | $125.67 |
Renaissance Technologies (RenTech)'s Elevance Health Investment FAQs
Renaissance Technologies (RenTech) first purchased Elevance Health, Inc. (ELV) in Q4 2014, acquiring 90,773 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Elevance Health, Inc. (ELV) for 41 quarters since Q4 2014.
Renaissance Technologies (RenTech)'s largest addition to Elevance Health, Inc. (ELV) was in Q2 2016, adding 1,196,973 shares worth $157.21 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 15,573 shares of Elevance Health, Inc. (ELV), valued at approximately $4.56 M.
As of the Q1 2026 filing, Elevance Health, Inc. (ELV) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Elevance Health, Inc. (ELV) was 1,686,773 shares, as reported at the end of Q4 2016.